79,080 Shares in Heartflow, Inc. $HTFL Acquired by Deutsche Bank AG

Deutsche Bank AG bought a new stake in shares of Heartflow, Inc. (NASDAQ:HTFL) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 79,080 shares of the company’s stock, valued at approximately $2,320,000.

Other institutional investors have also added to or reduced their stakes in the company. TrueMark Investments LLC increased its stake in shares of Heartflow by 1.4% in the 1st quarter. TrueMark Investments LLC now owns 26,885 shares of the company’s stock worth $654,000 after purchasing an additional 379 shares in the last quarter. Caitong International Asset Management Co. Ltd bought a new stake in Heartflow during the fourth quarter valued at about $27,000. Strs Ohio grew its holdings in Heartflow by 35.3% during the first quarter. Strs Ohio now owns 4,600 shares of the company’s stock valued at $112,000 after purchasing an additional 1,200 shares during the period. Russell Investments Group Ltd. purchased a new stake in Heartflow in the fourth quarter worth about $45,000. Finally, Legal & General Group Plc bought a new position in shares of Heartflow in the third quarter worth about $59,000.

Insiders Place Their Bets

In other Heartflow news, insider Campbell Rogers sold 9,219 shares of Heartflow stock in a transaction on Monday, August 17th. The shares were sold at an average price of $41.23, for a total value of $380,099.37. Following the sale, the insider directly owned 86,459 shares in the company, valued at approximately $3,564,704.57. The trade was a 9.64% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John C.M. Farquhar sold 27,230 shares of the business’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $50.00, for a total transaction of $1,361,500.00. Following the completion of the sale, the chief executive officer owned 360,814 shares in the company, valued at approximately $18,040,700. The trade was a 7.02% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 191,271 shares of company stock worth $7,089,136. 7.70% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. Weiss Ratings raised Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 7th. Piper Sandler restated an “overweight” rating and set a $45.00 target price (up from $38.00) on shares of Heartflow in a research note on Friday, August 14th. Freedom Capital raised shares of Heartflow to a “strong-buy” rating in a report on Tuesday, June 30th. Benchmark reiterated a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. Finally, Wells Fargo & Company increased their price objective on shares of Heartflow from $37.00 to $39.00 and gave the stock an “overweight” rating in a research note on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $43.43.

Heartflow Price Performance

HTFL stock opened at $48.10 on Friday. Heartflow, Inc. has a 1-year low of $20.13 and a 1-year high of $51.19. The business has a 50 day simple moving average of $31.97 and a two-hundred day simple moving average of $28.93. The company has a market capitalization of $4.18 billion and a price-to-earnings ratio of -26.28.

Heartflow (NASDAQ:HTFL) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The firm had revenue of $64.08 million for the quarter. The company’s quarterly revenue was up 47.7% compared to the same quarter last year. Sell-side analysts anticipate that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.